This page in English

Dritan Poci

Tjänstetitel: Affilierad forskare Organisation: Institutionen för medicinska vetenskaper

E-post:

Telefon: 019 303000 (växel)

Rum: -

Forskningsämne

Publikationer

Artiklar i tidskrifter |  Konferensbidrag | 

Artiklar i tidskrifter

Holmqvist, F. , Kesek, M. , Englund, A. , Blomström-Lundqvist, C. , Karlsson, L. O. , Kennebäck, G. , Poçi, D. , Samo-Ayou, R. & et al. (2019). A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes. European Heart Journal, 40 (10), 820-830.
Walfridsson, U. , Hansen, P. S. , Charitakis, E. , Almroth, H. , Jönsson, A. , Karlsson, L. O. , Liuba, I. , Ayou, R. S. & et al. (2019). Gender and age differences in symptoms and health-related quality of life in patients with atrial fibrillation referred for catheter ablation. Pacing and Clinical Electrophysiology, 42 (11), 1431-1439.
Poçi, D. (2019). Mitral Regurgitation, Atrial Fibrillation, and Transcatheter Mitral Valve Repair. JACC: Cardiovascular Interventions, 12 (6), 579-581.
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. & Poçi, D. (2018). Patient-Reported Outcomes in Relation to Continuously Monitored Rhythm Before and During 2 Years After Atrial Fibrillation Ablation Using a Disease-Specific and a Generic Instrument. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 7 (5).
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. & Poçi, D. (2018). Patient-reported outcomes in relation to continuously monitored rhythm before and during two years after atrial fibrillation ablation using a disease-specific and a generic instrument. European Heart Journal, 39 (Suppl. 1), 1415-1415.
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Svedberg, L. , Edvardsson, N. & Poçi, D. (2017). Assessment of Atrial Fibrillation–Specific Symptoms Before and 2 Years After Atrial Fibrillation Ablation: Do Patients and Physicians Differ in Their Perception of Symptom Relief?. JACC: Clinical Electrophysiology, 3 (10), 1168-1176.
Själander, S. , Holmqvist, F. , Smith, J. G. , Platonov, P. G. , Kesek, M. , Svensson, P. J. , Blomström-Lundqvist, C. , Tabrizi, F. & et al. (2017). Assessment of Use vs Discontinuation of Oral Anticoagulation After Pulmonary Vein Isolation in Patients With Atrial Fibrillation. JAMA cardiology, 2 (2), 146-152.
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Svedberg, L. , Edvardsson, N. & Poçi, D. (2017). Does zero atrial fibrillation burden after atrial fibrillation ablation mean that patients are free of symptoms?. Europace, Supplements, 19 (Duppl. 3), iii264-iii264.
Andersson, T. , Magnuson, A. , Bryngelsson, I. , Frøbert, O. , Henriksson, K. M. , Edvardsson, N. & Poçi, D. (2017). Patients without comorbidities at the time of diagnosis of atrial fibrillation: causes of death during long-term follow-up compared to matched controls. Clinical Cardiology, 40 (11), 1076-1082.
Björkenheim, A. , Brandes, A. , Chemnitz, A. , Magnuson, A. , Edvardsson, N. & Poçi, D. (2016). Rhythm Control and its Relation to Symptoms During the First Two Years After Radiofrequency Ablation for Atrial Fibrillation. Pacing and Clinical Electrophysiology, 39 (9), 914-925.
Andersson, T. , Magnuson, A. , Bryngelsson, I. , Fröbert, O. , Henriksson, K. M. , Edvardsson, N. & Poci, D. (2014). Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: A nationwide cohort study of 9519 patients. International Journal of Cardiology, 177 (1), 91-99.
Björkenheim, A. , Brandes, A. , Andersson, T. , Magnuson, A. , Edvardsson, N. , Wandt, B. , Pedersen, H. S. & Poci, D. (2014). Predictors of hospitalization for heart failure and of all-cause mortality after atrioventricular nodal ablation and right ventricular pacing for atrial fibrillation. Europace, 16 (12), 1772-1778.
Andersson, T. , Magnuson, A. , Bryngelsson, I. , Fröbert, O. , Henriksson, K. M. , Edvardsson, N. & Poci, D. (2013). All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study. European Heart Journal, 34 (14), 1061-1067.
Poci, D. , Abrahamsson, B. , Edvardsson, N. & Bergfeldt, L. (2013). Sinus Bradycardia and Sinus Pauses Immediately after Electrical Cardioversion of Persistent Atrial FibrillationWhat Do They Mean?. Annals of Noninvasive Electrocardiology, 18 (3), 281-287.
Poci, D. , Hartford, M. , Karlsson, T. , Edvardsson, N. & Caidahl, K. (2012). Effect of New Versus Known Versus No Atrial Fibrillation on 30-Day and 10-Year Mortality in Patients With Acute Coronary Syndrome. American Journal of Cardiology, 110 (2), 217-221.

Konferensbidrag

Poci, D. , Andersson, T. , Bryngelsson, I. , Magnuson, A. , Fröbert, O. , Henriksson, K. & Edvardsson, N. G. (2018). Do Some Patients Younger Than 65 Years Old And With Incident Atrial Fibrillation Need Anticoagulation Treatment?: Conclusions From A Swedish Nationwide Registry Study. Konferensbidrag vid HRS 39th Annual Scientific Sessions, Boston, USA, May 9-12, 2018.
Holmqvist, F. , Jonsson, A. , Kennebäck, G. , Blomström Lundqvist, C. , Sigurjonsdottir, R. , Kesek, M. , Englund, A. , Poci, D. & et al. (2018). Increasing Ablation Volumes And A Shift Towards More Complex Arrhythmias: Data From The Swedish National Catheter Ablation Registry. Konferensbidrag vid HRS 39th Annual Scientific Sessions, Boston, USA, May 9-12, 2018.
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. & Poci, D. (2018). Patient-reported outcomes in relation to continuously monitored rhythm before and during two years after atrial fibrillation ablation using a disease-specific and a generic instrument. Konferensbidrag vid European Society of Cardiology Congress 2018, Munich, Germany, August 25-29, 2018.
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. G. & Poci, D. (2018). Patient-reported Outcomes In Relation To Continuously Monitored Rhythm Before And During Two Years After Atrial Fibrillation Ablation Using A Disease-specific And A Generic Instrument. Konferensbidrag vid HRS 39th Annual Scientific Sessions, Boston, USA, May 9-12, 2018.
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Svedberg, L. , Edvardsson, N. & Poci, D. (2017). Is AF burden <0.5% a clinically meaningful criterion of success after AF ablation?. Konferensbidrag vid 13th Annual Congress of ECAS 2017, Rome, April 2-4, 2017.
Andersson, T. , Bryngelsson, I. L. , Magnuson, A. , Fröbert, O. , Henriksson, K. , Edvardsson, N. & Poci, D. (2017). What do patients with incident atrial fibrillation and no comorbidities at the time of diagnosis die of?. Konferensbidrag vid European Society of Cardiology Congress 2017, Barcelona, Spain, August 26-30, 2017. European Society of Cardiology.
Saliu, S. , Poçi, D. & Edwardsson, N. (2001). Parametric time-domain measures of long-term heart rate variability signal. I: 2001 Conference Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society. Konferensbidrag vid 23rd Annual International Conference of the IEEE-Engineering-in-Medicine-and-Biology-Society, Istanbul, Turkey, October 25-28, 2001 (ss. 1929-1932). IEEE.